Shareholding disclosure

Novartis International AG

Declared position

5%

Threshold

Fell below threshold

Timeline

Published

22.01.2004

Transaction

—

Voting rights breakdown

Voting rights acquired0%
Voting rights sold0%
Below threshold5%

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

T2394D2366

Beneficial owner

Novartis International AG

Declared address

Novartis International AG, Basel

Die Beteiligung an der Cytos Biotechnology AG wurde bis anhin von Novartis Venture Fund gemanagt und wird auch weiterhin von Novartis Venture Fund gemanagt werden.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open